Market Research Future published a research report on Myocardial Ischemia Market Research Report - Global Forecast till 2023 Report gives a clear picture of current market scenario which includes past and estimated future market size.
Leading Market Players
The market players in the global myocardial ischemia market are Boehringer Ingelheim International GmbH, Bayer AG, AstraZeneca, Taxus Cardium, ViroMed Co. Ltd., and Daiichi Sankyo Company Limited.
Myocardial Ischemia Industry Overview
The causes of myocardial ischemia, such as physical inactivity, high cholesterol, diabetes, etc., is inevitably deep-rooted in the changing lifestyle of the population across the world and is fueling the market growth. The recent report published by Market Research Future (MRFR) reveals the global Myocardial Ischemia Industrywill exhibit robust growth at 6.1% CAGR from 2017 to 2023.
Table of Content
4 Market Dynamics
4.2.1 High Prevalence of Coronary Heart Disease
4.2.2 Rising Prevalence of Diabetes
4.2.3 Lifestyle Changes
4.2.4 Drivers Impact Analysis
4.3.1 High Cost of Therapeutic Surgeries
4.3.2 Side Effects Related to Medications
4.3.3 Restraints Impact Analysis
4.4.1 Untapped markets of the Asia-Pacific region
4.5 Macroeconomic Indicator
5 Market Factor Analysis
5.1 Value Chain Analysis
5.1.1 R&D and Designing
5.1.3 Distribution & Sales
5.1.4 Post-Sales Review
5.2 Porter’s Five Forces Model
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Buyers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitutes
5.2.5 Intensity of Rivalry
5.3 Investment Opportunities
5.4 Pricing Analysis
5.5 Demand & Supply: Gap Analysis
Global Market for Myocardial Ischemia – Segmental Analysis
By type, the market is segmented on the basis of symptomatic and asymptomatic. The asymptomatic (silent) myocardial ischemia segment accounted for the largest market share in 2017. Growing number of smokers, family history of heart diseases, prevalence of cases of high cholesterol and high blood pressure, and lack of exercise can drive the growth in the segment.
By treatment & diagnosis, the market is segmented into treatment and diagnosis. The diagnosis segment is sub-segmented into imaging and stress test. On the other hand, the treatment segment is sub-segmented into medications and surgery. The treatment segment has gained significant traction owing to increasing prevalence of coronary heart disease and large population leading a stressful lifestyle.
The end-users, hospitals & clinics, diagnostic centers, ambulatory surgery centers, and others.
Geographically, the global myocardial ischemia market is spread across the Americas, Europe, Asia Pacific, and the Middle East and Africa.
MRFR noted that the Americas accounted for the largest market share and will maintain its dominance throughout the forecast period. The Americas market is presumed to reach USD 18,130.3 million by 2023 at a CAGR of 6.21% from 2017 to 2023. This position was achieved due to rising prevalence of diabetes, obesity, lack of physical inactivity, and excessive alcohol consumption among the population in the region.
After America, Europe holds the largest market share owing to high number of cases related to cardiovascular diseases. Revolutionary technology, rising healthcare infrastructure, continuous researches conducted to enhance treatment procedures, and easy access to medical facilities and medication has led to market growth in the region. Moreover, obesity and stressful schedules have given way to expansion of the market considerably.
Asia Pacific is expected to garner high revenues at the fastest growth rate of about 6.42% during the forecast period due to rising prevalence of diabetes. Growing awareness about cardiovascular diseases and increasing geriatric population are major driving factors of the market in the region. Moreover, growing economies in the region and rising investments in healthcare facilities along with a growing number of hospitals make sure that the market gains significant traction in the region. Apart from these factors, government initiatives to generate awareness and knowledge regarding health issues also propel the market growth.
Global Myocardial Ischemia Market: Information by Type (Symptomatic and Asymptomatic), Treatment & Diagnosis (Diagnosis and Treatment), End User (Hospitals & Clinics, Diagnostic Centers and Ambulatory Surgery Centers) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2023 please visit @ https://www.marketresearchfuture.com/reports/myocardial-ischemia-market-5811
AstraZeneca will expand its Global Medicines Development (GMD) unit in Bengaluru, India. The site which will be inaugurated is one of the nine global sites that will support clinical trials, monitor safety, efficacy and other regulatory management required during a product’s lifecycle. The center will support India as well as the work done globally by the organization.
Browse Other Healthcare Related Reports
Medicated Personal Care Products Market - Forecast to 2027
Global Bionic Eye Market - Forecast To 2027
About Market Research Future:
MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.